Identifying Regulators of Cellular Aging that can Prevent Alzheimer's Disease

识别可以预防阿尔茨海默病的细胞衰老调节因子

• 批准号: 10383454
• 负责人: Benjamin Jacob Doranz
• 金额: $ 35.86万
• 依托单位: INTEGRAL MOLECULAR
• 依托单位国家: 美国
• 财政年份: 2022
• 资助国家: 美国
• 起止时间: 2022-06-01 至 2023-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10383454
• 关键词: Abbreviations; Aging; Alzheimer' s Disease; Alzheimer' s disease risk; Alzheimer' s disease therapeutic; Antibodies; Astrocytes; Biological Assay; Biological Markers; Biological Models; Biological Products; Cell Aging; Cells; Cellular Stress; Chronic Disease; Clinical Trials; DNA Damage; DNA Methylation; DNA Repair; Disease; Drug Targeting; Engineering; Epigenetic Process; Future; Gene Expression; Generations; Genes; Genomic Instability; Health; Human; Internal Ribosome Entry Site; Libraries; Link; Longevity; Membrane; Methods; Microglia; Mitochondria; Modeling; Molecular Conformation; Monitor; Nutritional; Outcome; Oxidative Stress; Pathway interactions; Patients; Pharmaceutical Preparations; Pharmacology; Phenotype; Plasmids; Play; Prevention; Process; Proteins; Proteome; Reactive Oxygen Species; Receptor Cell; Reporter; Role; Source; Stress Tests; T-Lymphocyte; Technology; Testing; Therapeutic; Therapeutic Intervention; TimeLine; Transfection; Translating; Virus Receptors; Work; base; cell age; cell growth regulation; comorbidity; expression vector; gene product; gene therapy; healthspan; immune checkpoint; improved; metaplastic cell transformation; methylation biomarker; mitochondrial dysfunction; mouse model; new therapeutic target; oxidation; phase 2 study; prevent; programs; proteostasis; stem cell biology; stem cells; targeted treatment; telomere; therapeutic target; transcription factor

ABSTRACT Aging is the leading risk factor for Alzheimer’s Disease (AD) and many other chronic diseases, with more than 6.5 million cases of AD in the US. Regulating or slowing cellular aging, particularly in microglia and astrocytes that regulate neuroimmunity, would have a major impact on the treatment of AD, but the proteins that control cellular aging processes are poorly understood. Cellular aging has been characterized into 9 “hallmarks” or phenotypes that define aged cells. Most hallmarks are a result of cellular stress, such as DNA damage and oxidation, and are inter-related in both their causes and outcomes. The cellular aging process is linked to dramatically altered gene expression, which is largely controlled by transcription factors (TFs). Longevity studies between species also suggest that TF activity can define the rate of aging. We hypothesize that TFs can modulate cellular aging and that identifying the TFs that play a role in aging processes will enable an entirely new generation of therapeutic targets with the potential to treat, delay, and possibly even prevent AD. The discovery of TFs that can improve the lifespan of patients would have a profound impact on the prevention and treatment of AD and many other diseases.

抽象的 衰老是阿尔茨海默病 (AD) 和许多其他慢性疾病的主要危险因素，超过 美国有 650 万例 AD 病例，调节或减缓细胞衰老，特别是小胶质细胞和星形胶质细胞。 调节神经免疫的蛋白质将对 AD 的治疗产生重大影响，但控制神经免疫的蛋白质 人们对细胞衰老过程知之甚少 细胞衰老被分为 9 个“标志”或 定义衰老细胞的大多数特征是细胞应激的结果，例如 DNA 损伤和 氧化，并且其原因和结果都是相互关联的，细胞衰老过程与细胞衰老过程有关。 基因表达发生显着改变，这主要是由转录因子（TF）控制的。 物种间的研究还表明 TF 活性可以定义衰老速度。 可以调节细胞衰老，识别在衰老过程中发挥作用的转录因子将能够 全新的一代治疗靶点，具有治疗、延缓甚至预防 AD 的潜力。 能够延长患者寿命的转录因子的发现将对预防产生深远的影响 以及 AD 和许多其他疾病的治疗。